Casey Woodring
Stock Analyst at J.P. Morgan
(3.76)
# 2,059
Out of 4,651 analysts
193
Total ratings
59.2%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Maintained: Buy | $50 | $42.95 | +16.41% | 20 | Aug 10, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $38 → $50 | $56.09 | -10.86% | 5 | Aug 10, 2026 | |
| SHC Sotera Health Company | Maintained: Hold | $16 → $18 | $18.89 | -4.71% | 15 | Aug 10, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Buy | $32 → $35 | $33.16 | +5.55% | 3 | Aug 10, 2026 | |
| NTRA Natera | Reiterated: Buy | $315 → $360 | $309.93 | +16.16% | 6 | Aug 7, 2026 | |
| BRKR Bruker | Maintained: Buy | $65 → $60 | $57.70 | +3.99% | 4 | Aug 6, 2026 | |
| RVTY Revvity | Maintained: Hold | $90 → $110 | $116.84 | -5.85% | 4 | Aug 6, 2026 | |
| WAT Waters | Maintained: Hold | $370 → $400 | $412.17 | -2.95% | 6 | Aug 6, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $30 → $25 | $21.80 | +14.68% | 5 | Aug 6, 2026 | |
| BLLN BillionToOne | Reiterated: Buy | $145 → $130 | $93.33 | +39.29% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $160 → $310 | $280.05 | +10.69% | 22 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $155 → $165 | $163.15 | +1.13% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 | $190.89 | +20.49% | 8 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1,200 → $1,400 | $1,419.02 | -1.34% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $195 | $157.21 | +24.04% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $45 | $52.10 | -13.63% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $13.66 | -12.15% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $175 | $166.83 | +4.90% | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $255 → $285 | $236.66 | +20.43% | 2 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 → $690 | $588.29 | +17.29% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $220 | $202.45 | +8.67% | 8 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $11 → $12 | $14.30 | -16.08% | 19 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 | $148.53 | +21.19% | 4 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $3.84 | n/a | 5 | Aug 9, 2024 |
Qiagen
Aug 10, 2026
Maintained: Buy
Price Target: $50
Current: $42.95
Upside: +16.41%
10x Genomics
Aug 10, 2026
Maintained: Hold
Price Target: $38 → $50
Current: $56.09
Upside: -10.86%
Sotera Health Company
Aug 10, 2026
Maintained: Hold
Price Target: $16 → $18
Current: $18.89
Upside: -4.71%
Alamar Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $32 → $35
Current: $33.16
Upside: +5.55%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $315 → $360
Current: $309.93
Upside: +16.16%
Bruker
Aug 6, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $57.70
Upside: +3.99%
Revvity
Aug 6, 2026
Maintained: Hold
Price Target: $90 → $110
Current: $116.84
Upside: -5.85%
Waters
Aug 6, 2026
Maintained: Hold
Price Target: $370 → $400
Current: $412.17
Upside: -2.95%
Caris Life Sciences
Aug 6, 2026
Maintained: Buy
Price Target: $30 → $25
Current: $21.80
Upside: +14.68%
BillionToOne
Aug 6, 2026
Reiterated: Buy
Price Target: $145 → $130
Current: $93.33
Upside: +39.29%
Aug 5, 2026
Upgraded: Buy
Price Target: $160 → $310
Current: $280.05
Upside: +10.69%
Aug 4, 2026
Maintained: Hold
Price Target: $155 → $165
Current: $163.15
Upside: +1.13%
Aug 4, 2026
Maintained: Buy
Price Target: $230
Current: $190.89
Upside: +20.49%
Aug 4, 2026
Maintained: Hold
Price Target: $1,200 → $1,400
Current: $1,419.02
Upside: -1.34%
Aug 4, 2026
Maintained: Buy
Price Target: $195
Current: $157.21
Upside: +24.04%
Aug 4, 2026
Maintained: Hold
Price Target: $50 → $45
Current: $52.10
Upside: -13.63%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $12
Current: $13.66
Upside: -12.15%
Jul 29, 2026
Rated: Buy
Price Target: $165 → $175
Current: $166.83
Upside: +4.90%
Jul 29, 2026
Rated: Buy
Price Target: $255 → $285
Current: $236.66
Upside: +20.43%
Jul 28, 2026
Maintained: Buy
Price Target: $600 → $690
Current: $588.29
Upside: +17.29%
Jul 23, 2026
Maintained: Buy
Price Target: $245 → $220
Current: $202.45
Upside: +8.67%
Jul 1, 2026
Rated: Sell
Price Target: $11 → $12
Current: $14.30
Upside: -16.08%
May 27, 2026
Maintained: Buy
Price Target: $180
Current: $148.53
Upside: +21.19%
Aug 9, 2024
Maintained: Hold
Price Target: $6 → $5
Current: $3.84
Upside: n/a